Kishi Yoji, Edo Hiromi, Mikoshi Ayako, Okano Kousuke, Tsunenari Takazumi, Einama Takahiro, Takao Mikiya, Okamoto Koichi, Kajiwara Yoshiki, Ueno Hideki, Ogata Sho, Matsukuma Susumu, Shinmoto Hiroshi
Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
Department of Radiology, National Defense Medical College, Tokorozawa, Japan.
Abdom Radiol (NY). 2025 Aug 18. doi: 10.1007/s00261-025-05152-y.
This prospective study aimed to compare the diagnostic accuracy of hepatic lesions between contrast-enhanced computed tomography (CE-CT) and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (Gd-EOB-MRI). We also examined the final diagnosis of equivocal lesions.
In each patient undergoing hepatectomy for liver tumors, 2 radiologists (readers A and B) assessed CE-CT and Gd-EOB-MRI. Hepatic lesions were scored as 1, 2, 3, 4, or 5, which corresponded to categorization as benign, probably benign, equivocal, probably malignant, or malignant, respectively. Those scored as 1/2 and 4/5 were defined as benign and malignant, respectively. The lesions left unresected were confirmed as benign when they remained unchanged for ≥ 1 year after hepatectomy. The false-positive rate was defined as the number of lesions finally confirmed as benign among those assessed as malignant preoperatively.
Among 105 enrolled patients (colorectal liver metastases, 72; hepatocellular carcinoma, 29; other, 4), 886 lesions were recognized on either CT or MRI preoperatively; another 26 lesions were identified only on intraoperative ultrasonography or pathologic examination. The sensitivity of malignant lesion detection was significantly higher for Gd-EOB-MRI than CE-CT for both reader A (90.3% vs. 68.3%; P < 0.001) and reader B (88.1% vs. 70.2%; P < 0.001). The false-positive rate with CE-CT and Gd-EOB-MRI was 2.3% and 3.7%, respectively, for reader A (P = 0.580), and 0.5% and 4.2%, respectively, for reader B (P = 0.033). There were 142 lesions judged as equivocal in at least one of the imaging studies by either reader. Sixty-eight lesions (49%) were recognized as malignant by any of the alternative assessments; among these, 61were confirmed as malignant.
Gd-EOB-MRI was superior to CE-CT for detecting liver lesions. The false-positive rate was low for both modalities. Equivocal lesions were encountered frequently, but routine use of alternate modalities and evaluation by 2 or more radiologists could enhance the accuracy of diagnosis.
本前瞻性研究旨在比较对比增强计算机断层扫描(CE-CT)和钆塞酸二钠增强磁共振成像(Gd-EOB-MRI)对肝脏病变的诊断准确性。我们还研究了可疑病变的最终诊断情况。
在每例因肝肿瘤接受肝切除术的患者中,2名放射科医生(A和B阅片者)对CE-CT和Gd-EOB-MRI进行评估。肝脏病变分为1、2、3、4或5分,分别对应良性、可能良性、可疑、可能恶性或恶性。评分为1/2分和4/5分的病变分别定义为良性和恶性。肝切除术后≥1年未切除的病变若保持不变则确认为良性。假阳性率定义为术前评估为恶性但最终确认为良性病变的数量。
在105例入组患者中(结直肠癌肝转移72例;肝细胞癌29例;其他4例),术前CT或MRI共识别出886个病变;另外26个病变仅在术中超声检查或病理检查中发现。A阅片者和B阅片者中,Gd-EOB-MRI检测恶性病变的敏感性均显著高于CE-CT(A阅片者:90.3%对68.3%;P<0.001;B阅片者:88.1%对70.2%;P<0.001)。A阅片者中,CE-CT和Gd-EOB-MRI的假阳性率分别为2.3%和3.7%(P=0.580);B阅片者中分别为0.5%和4.2%(P=0.033)。至少在一项影像学检查中被任一阅片者判定为可疑病变者有142个;其中68个病变(49%)在任何其他评估中被判定为恶性,其中61个被确认为恶性。
Gd-EOB-MRI在检测肝脏病变方面优于CE-CT;两种检查方式假阳性率均较低。可疑病变常见,但常规使用替代检查方式并由2名或更多放射科医生评估可提高诊断准确性。